Do analysts prefer CXF or AIM?

Aimia has a consensus target price of C$3.00, indicating a potential upside of 3.45%. Given Aimia's stronger consensus rating and higher probable upside, analysts clearly believe Aimia is more favorable than CI Canadian Convertible Bond ETF Common. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CI Canadian Convertible Bond ETF Common 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Aimia 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher earnings and valuation, CXF or AIM?

CI Canadian Convertible Bond ETF Common has higher earnings, but lower revenue than Aimia. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CI Canadian Convertible Bond ETF Common N/A N/A N/A N/A N/A Aimia C$476.60M 0.54 -C$78.81M -C$0.15 N/A

Do analysts recommend CXF or GPH?

Graphite One has a consensus price target of C$2.50, indicating a potential upside of 150.00%. Given Graphite One's stronger consensus rating and higher probable upside, analysts plainly believe Graphite One is more favorable than CI Canadian Convertible Bond ETF Common. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CI Canadian Convertible Bond ETF Common 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Graphite One 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has stronger earnings and valuation, CXF or GPH?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CI Canadian Convertible Bond ETF Common N/A N/A N/A N/A N/A Graphite One N/A N/A -C$4.90M -C$0.07 N/A

Is CXF or GPH more profitable?

CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Graphite One's return on equity. Company Net Margins Return on Equity Return on Assets CI Canadian Convertible Bond ETF Common N/A N/A N/A Graphite One N/A -14.13% -6.61%

Which has stronger valuation & earnings, CRDL or CXF?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardiol Therapeutics N/A N/A -C$42.93M -C$0.39 N/A CI Canadian Convertible Bond ETF Common N/A N/A N/A N/A N/A

Is CRDL or CXF more profitable?

CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Cardiol Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Cardiol Therapeutics N/A -229.16% -54.15% CI Canadian Convertible Bond ETF Common N/A N/A N/A

Which has preferable earnings & valuation, CXF or IPA?

CI Canadian Convertible Bond ETF Common has higher earnings, but lower revenue than ImmunoPrecise Antibodies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CI Canadian Convertible Bond ETF Common N/A N/A N/A N/A N/A ImmunoPrecise Antibodies C$19.47M 8.33 -C$22.19M -C$0.89 N/A

Is CXF or IPA more profitable?

Company Net Margins Return on Equity Return on Assets CI Canadian Convertible Bond ETF Common N/A N/A N/A ImmunoPrecise Antibodies N/A N/A N/A

Which has better valuation & earnings, APM or CXF?

Andean Precious Metals has higher revenue and earnings than CI Canadian Convertible Bond ETF Common. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Andean Precious Metals C$154.78M 0.88 C$37.41M C$0.51 2.55 CI Canadian Convertible Bond ETF Common N/A N/A N/A N/A N/A

CI Canadian Convertible Bond ETF Common (CXF) Competitors

C$10.70 +0.07 (+0.66%)

As of 07/7/2026 02:31 PM Eastern

Compare

CXF vs. AIM, GPH, CRDL, IPA, and APM

Should you buy CI Canadian Convertible Bond ETF Common stock or one of its competitors? MarketBeat compares CI Canadian Convertible Bond ETF Common with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CI Canadian Convertible Bond ETF Common include Aimia (AIM), Graphite One (GPH), Cardiol Therapeutics (CRDL), ImmunoPrecise Antibodies (IPA), and Andean Precious Metals (APM). These companies are all part of the "pharmaceutical products" industry.

How does CI Canadian Convertible Bond ETF Common compare to Aimia?

CI Canadian Convertible Bond ETF Common (TSE:CXF) and Aimia (TSE:AIM) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

CI Canadian Convertible Bond ETF Common has a net margin of 0.00% compared to Aimia's net margin of -3.17%. CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Aimia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A
Aimia	-3.17%	-3.98%	-4.93%

CI Canadian Convertible Bond ETF Common has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market. Comparatively, Aimia has a beta of 0.176025, meaning that its share price is 82% less volatile than the broader market.

Aimia has a consensus target price of C$3.00, indicating a potential upside of 3.45%. Given Aimia's stronger consensus rating and higher probable upside, analysts clearly believe Aimia is more favorable than CI Canadian Convertible Bond ETF Common.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CI Canadian Convertible Bond ETF Common	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Aimia	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

CI Canadian Convertible Bond ETF Common has higher earnings, but lower revenue than Aimia.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A	N/A	N/A
Aimia	C$476.60M	0.54	-C$78.81M	-C$0.15	N/A

In the previous week, Aimia had 1 more articles in the media than CI Canadian Convertible Bond ETF Common. MarketBeat recorded 1 mentions for Aimia and 0 mentions for CI Canadian Convertible Bond ETF Common. Aimia's average media sentiment score of 0.90 beat CI Canadian Convertible Bond ETF Common's score of 0.00 indicating that Aimia is being referred to more favorably in the news media.

Company	Overall Sentiment
CI Canadian Convertible Bond ETF Common	Neutral
Aimia	Positive

8.3% of Aimia shares are owned by institutional investors. 3.3% of Aimia shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Aimia beats CI Canadian Convertible Bond ETF Common on 7 of the 11 factors compared between the two stocks.

How does CI Canadian Convertible Bond ETF Common compare to Graphite One?

CI Canadian Convertible Bond ETF Common (TSE:CXF) and Graphite One (CVE:GPH) are both small-cap pharmaceutical products companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends.

In the previous week, Graphite One had 2 more articles in the media than CI Canadian Convertible Bond ETF Common. MarketBeat recorded 2 mentions for Graphite One and 0 mentions for CI Canadian Convertible Bond ETF Common. Graphite One's average media sentiment score of 0.41 beat CI Canadian Convertible Bond ETF Common's score of 0.00 indicating that Graphite One is being referred to more favorably in the news media.

Company	Overall Sentiment
CI Canadian Convertible Bond ETF Common	Neutral
Graphite One	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A	N/A	N/A
Graphite One	N/A	N/A	-C$4.90M	-C$0.07	N/A

Graphite One has a consensus price target of C$2.50, indicating a potential upside of 150.00%. Given Graphite One's stronger consensus rating and higher probable upside, analysts plainly believe Graphite One is more favorable than CI Canadian Convertible Bond ETF Common.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CI Canadian Convertible Bond ETF Common	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Graphite One	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Graphite One's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A
Graphite One	N/A	-14.13%	-6.61%

0.0% of Graphite One shares are held by institutional investors. 28.8% of Graphite One shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

CI Canadian Convertible Bond ETF Common has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market. Comparatively, Graphite One has a beta of 1.350961, meaning that its share price is 35% more volatile than the broader market.

Summary

Graphite One beats CI Canadian Convertible Bond ETF Common on 8 of the 10 factors compared between the two stocks.

How does CI Canadian Convertible Bond ETF Common compare to Cardiol Therapeutics?

Cardiol Therapeutics (TSE:CRDL) and CI Canadian Convertible Bond ETF Common (TSE:CXF) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

In the previous week, Cardiol Therapeutics' average media sentiment score of 0.00 equaled CI Canadian Convertible Bond ETF Common'saverage media sentiment score.

Company	Overall Sentiment
Cardiol Therapeutics	Neutral
CI Canadian Convertible Bond ETF Common	Neutral

Cardiol Therapeutics has a beta of 0.300183, indicating that its stock price is 70% less volatile than the broader market. Comparatively, CI Canadian Convertible Bond ETF Common has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardiol Therapeutics	N/A	N/A	-C$42.93M	-C$0.39	N/A
CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A	N/A	N/A

CI Canadian Convertible Bond ETF Common's return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardiol Therapeutics	N/A	-229.16%	-54.15%
CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A

0.1% of Cardiol Therapeutics shares are owned by institutional investors. 4.6% of Cardiol Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

CI Canadian Convertible Bond ETF Common beats Cardiol Therapeutics on 3 of the 5 factors compared between the two stocks.

How does CI Canadian Convertible Bond ETF Common compare to ImmunoPrecise Antibodies?

CI Canadian Convertible Bond ETF Common (TSE:CXF) and ImmunoPrecise Antibodies (CVE:IPA) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations.

Company	Net Margins	Return on Equity	Return on Assets
CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A
ImmunoPrecise Antibodies	N/A	N/A	N/A

CI Canadian Convertible Bond ETF Common has higher earnings, but lower revenue than ImmunoPrecise Antibodies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A	N/A	N/A
ImmunoPrecise Antibodies	C$19.47M	8.33	-C$22.19M	-C$0.89	N/A

In the previous week, CI Canadian Convertible Bond ETF Common's average media sentiment score of 0.00 equaled ImmunoPrecise Antibodies'average media sentiment score.

Company	Overall Sentiment
CI Canadian Convertible Bond ETF Common	Neutral
ImmunoPrecise Antibodies	Neutral

Summary

ImmunoPrecise Antibodies beats CI Canadian Convertible Bond ETF Common on 1 of the 1 factors compared between the two stocks.

How does CI Canadian Convertible Bond ETF Common compare to Andean Precious Metals?

Andean Precious Metals (CVE:APM) and CI Canadian Convertible Bond ETF Common (TSE:CXF) are both small-cap manufacturing companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and institutional ownership.

Andean Precious Metals has higher revenue and earnings than CI Canadian Convertible Bond ETF Common.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Andean Precious Metals	C$154.78M	0.88	C$37.41M	C$0.51	2.55
CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A	N/A	N/A

In the previous week, Andean Precious Metals had 1 more articles in the media than CI Canadian Convertible Bond ETF Common. MarketBeat recorded 1 mentions for Andean Precious Metals and 0 mentions for CI Canadian Convertible Bond ETF Common. Andean Precious Metals' average media sentiment score of 1.48 beat CI Canadian Convertible Bond ETF Common's score of 0.00 indicating that Andean Precious Metals is being referred to more favorably in the media.

Company	Overall Sentiment
Andean Precious Metals	Positive
CI Canadian Convertible Bond ETF Common	Neutral

Andean Precious Metals has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market. Comparatively, CI Canadian Convertible Bond ETF Common has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market.

13.2% of Andean Precious Metals shares are owned by institutional investors. 69.4% of Andean Precious Metals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Andean Precious Metals has a net margin of 23.59% compared to CI Canadian Convertible Bond ETF Common's net margin of 0.00%. Andean Precious Metals' return on equity of 18.47% beat CI Canadian Convertible Bond ETF Common's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Andean Precious Metals	23.59%	18.47%	4.13%
CI Canadian Convertible Bond ETF Common	N/A	N/A	N/A

Summary

Andean Precious Metals beats CI Canadian Convertible Bond ETF Common on 9 of the 9 factors compared between the two stocks.

Get CI Canadian Convertible Bond ETF Common News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CXF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CXF vs. The Competition

Export

Metric	CI Canadian Convertible Bond ETF Common	Pharmaceutical Preparations Industry	Manufacturing Sector	TSE Exchange
Market Cap	C$60.96M	C$963.13M	C$5.17B	C$13.09B
Dividend Yield	4.84%	4.84%	19.00%	6.17%
P/E Ratio	N/A	1.57	23.67	36.24
Price / Sales	N/A	114.93	165.68	10.00
Price / Cash	N/A	20.06	34.70	82.29
Price / Book	N/A	8.38	13.13	4.44
Net Income	N/A	-C$3.96M	C$116.30M	C$299.09M
7 Day Performance	0.66%	-1.10%	-0.95%	0.46%
1 Month Performance	0.66%	3.71%	0.02%	0.41%
1 Year Performance	3.38%	48.56%	10.05%	33.82%

CI Canadian Convertible Bond ETF Common Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CXF CI Canadian Convertible Bond ETF Common	N/A	C$10.70 +0.7%	N/A	+4.1%	C$60.96M	N/A	N/A	90
AIM Aimia	1.9034 of 5 stars	C$2.69 -0.7%	C$3.00 +11.5%	-2.0%	C$238.24M	C$476.60M	N/A	20
GPH Graphite One	2.0065 of 5 stars	C$1.00 +2.0%	C$2.85 +185.0%	+40.8%	C$208.97M	N/A	N/A	20	Positive News
CRDL Cardiol Therapeutics	N/A	C$1.49 flat	N/A	-25.4%	C$171.76M	N/A	N/A	20
IPA ImmunoPrecise Antibodies	N/A	C$6.50 +0.8%	N/A	+0.0%	C$162.08M	C$19.47M	N/A	80	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:CXF) was last updated on 7/8/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CI Canadian Convertible Bond ETF Common (CXF) Competitors

CXF vs. AIM, GPH, CRDL, IPA, and APM

How does CI Canadian Convertible Bond ETF Common compare to Aimia?

Summary

How does CI Canadian Convertible Bond ETF Common compare to Graphite One?

Summary

How does CI Canadian Convertible Bond ETF Common compare to Cardiol Therapeutics?

Summary

How does CI Canadian Convertible Bond ETF Common compare to ImmunoPrecise Antibodies?

Summary

How does CI Canadian Convertible Bond ETF Common compare to Andean Precious Metals?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CXF vs. The Competition

CI Canadian Convertible Bond ETF Common Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CI Canadian Convertible Bond ETF Common (CXF) Competitors

CXF vs. AIM, GPH, CRDL, IPA, and APM

How does CI Canadian Convertible Bond ETF Common compare to Aimia?

Is CXF or AIM more profitable?

Which has more volatility and risk, CXF or AIM?

Do analysts prefer CXF or AIM?

Which has higher earnings and valuation, CXF or AIM?

Does the media refer more to CXF or AIM?

Do institutionals and insiders believe in CXF or AIM?

Summary

How does CI Canadian Convertible Bond ETF Common compare to Graphite One?

Does the media prefer CXF or GPH?

Which has stronger earnings and valuation, CXF or GPH?

Do analysts recommend CXF or GPH?

Is CXF or GPH more profitable?

Do institutionals & insiders believe in CXF or GPH?

Which has more risk and volatility, CXF or GPH?

Summary

How does CI Canadian Convertible Bond ETF Common compare to Cardiol Therapeutics?

Does the media favor CRDL or CXF?

Which has more risk and volatility, CRDL or CXF?

Which has stronger valuation & earnings, CRDL or CXF?

Is CRDL or CXF more profitable?

Do institutionals and insiders hold more shares of CRDL or CXF?

Summary

How does CI Canadian Convertible Bond ETF Common compare to ImmunoPrecise Antibodies?

Is CXF or IPA more profitable?

Which has preferable earnings & valuation, CXF or IPA?

Does the media favor CXF or IPA?

Summary

How does CI Canadian Convertible Bond ETF Common compare to Andean Precious Metals?

Which has better valuation & earnings, APM or CXF?

Does the media favor APM or CXF?

Which has more risk & volatility, APM or CXF?

Do institutionals & insiders believe in APM or CXF?

Is APM or CXF more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CXF vs. The Competition

CI Canadian Convertible Bond ETF Common Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools